FOXP3 and melanoma: Despite these limitations, our study suggests that the simultaneous quantification by multiplex IHC of CD3, FOXP3 and GRZB-positive T cells in the same tissue area, and the application of the suggested ratio, can be a useful tool for the stratification of melanoma patients that may or may not benefit from anti-PD-1 treatment.